Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer.

Cancer Metastasis Reviews
Molly A NelsonWassana Yantasee

Abstract

Increased levels of total tumor-infiltrating lymphocytes (TILs) are generally associated with good prognosis in several breast cancer subtypes. Subtypes of TILs impact both tumor cells and immune cells in a variety of different ways, leading to either a pro-tumor or antitumor effect. Tumor-infiltrating CD8+ T cells and natural killer (NK) cells perform as effector cells against tumor cells and are associated with better clinical outcome. Immunotherapy approaches that improve the antitumor activity and proliferation of CD8+ T and NK cells include PD-1/PD-L1 blockade, CAR T cell therapy, or ex vivo-stimulated NK cells. A subset of CD8+ T cells, tissue-resident memory T cells, has also recently been associated with good prognosis in breast cancer patients, and has potential to serve as a predictive biomarker and therapeutic target. Tumor-infiltrating B cells also secrete apoptosis-inducing IgG antibodies and can act as antigen-presenting cells to prime CD4+ and CD8+ T cells. On the other hand, regulatory T and regulatory B cells modulate the immune response from CD8+ T cells and NK cells by secreting immunosuppressive cytokines and inhibiting maturation of antigen-presenting cells (APCs). These regulatory cells are typically assoc...Continue Reading

References

Dec 1, 1985·The Journal of Experimental Medicine·H G Ljunggren, K Kärre
Nov 18, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L DisisM A Cheever
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B AlmandD I Gabrilovich
Nov 8, 2001·Trends in Immunology·M A CooperM A Caligiuri
Aug 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julia A CoronellaEvan M Hersh
Aug 28, 2002·Immunity·Alison V CollinsSimon J Davis
Dec 14, 2002·Science·Nadia L BernasconiAntonio Lanzavecchia
Feb 20, 2003·The Journal of Experimental Medicine·Claudia MauriMarco Londei
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vrajesh V ParekhGyan C Mishra
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Donghua WangGregg A Hadley
Feb 27, 2004·Cancer Immunology, Immunotherapy : CII·Inge Marie SvaneMogens H Claesson
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roberto GennariAlberto Costa
Sep 16, 2006·Nature Reviews. Immunology·Andreas RadbruchFalk Hiepe
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gaynor J BatesAlison H Banham
Nov 23, 2007·Nature·Lauren W CollisonDario A A Vignali
Mar 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vicky LampropoulouSimon Fillatreau
Apr 22, 2008·Nature Immunology·Lewis L Lanier
May 20, 2008·Journal of Translational Medicine·Alessandra BeanoLina Matera
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
Jul 3, 2008·Cancer Research·Marcus SchmidtMathias Gehrmann
Aug 30, 2008·Blood·Tucker W LeBien, Thomas F Tedder
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jessica MårlindDario Neri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis